Skip to Main Content
Yale Center for Clinical Investigation
YSM Home

INFORMATION FOR

COVID-19 Vaccine | Infectious Diseases, Phase III

The TIPI Study

What is the purpose of this trial?

The purpose of this research is to find out if a single dose of pre-travel vaccination with BCG (a living organism preparation) can lessen Tuberculosis (TB) infection by producing an immune response (development of TB fighter cells within the body) when given to adults traveling to countries with a high burden of TB. BCG will be compared with a placebo (an inactive vaccine). Participants will be randomly assigned (this is like a coin flip) to receive BCG vaccine or placebo.

  • Trial with
    Henry M. Jackson Foundation for the Advancement of Military Medicine
  • Ages
    18 years - 65 years
  • Gender
    Both
Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Anousheh Behnegar

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

  • Last Updated
    08/22/2023
  • Study HIC
    #2000028329

Contact Information

For more information about this study, including how to volunteer, contact Anousheh Behnegar